Recombinant human endostatin (rh-Endo) is a molecular targeted therapeutic drug, which has the effect of inhibiting tumor growth, invasion, and metastasis with little damage to normal vascular endothelial cells; moreover, it can specifically inhibit tumor tissues, with less toxic and side effects and strong pertinence [16]. Here, COL18A1 is linked to neoplasm.